News

Medical robotics firm treating upper extremity paralysis explores going public

Ziad2022-11-25T14:06:06-05:00Cambridge, Massachusetts-based Myomo announced Friday that it is taking advantage of new SEC provisions that allow early-stage companies to raise capital without restricting it to only accredited investors Through the Regulation A+ provision, which is an amendment to Regulation A, the Securities & Exchange Commission adopted rules that went into effect June 2015 allowing early-stage companies to raise a maximum of $50 million from the public. They are known as mini-IPOs and mark a pivotal moment given the agency accepted equity crowdfunding...

Myomo Files for Reg A+ Offer. Expects to List on NYSE Following Funding Round

Ziad2022-11-25T14:06:06-05:00Myomo, a medical robotics company whose products enable users to overcome upper extremity paralysis, has filed a Form 1-A with the SEC indicating its intent to raise money under Reg A+, a crowdfunding exemption that allows issuers to seek up to $50 million in capital. Read more >>

Myomo registers for IPO

Ziad2022-11-25T14:06:06-05:00Myomo said today it filed with the SEC for an initial public offering, looking to register on the NYSE under the ticker symbol “MYO”. Myomo develops and produces myoelectric orthotics for patients with neuromuscular disorders, including its flagship MyoPro line. The orthosis devices are non-invasive, powered braces used to support weak or deformed arms and hands to allow for functional activity. Read more >>